Trevi Therapeutics, Inc. (TRVI) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Trevi Therapeutics, Inc. (TRVI) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

TRVI Income Statement

Trevi Therapeutics, Inc. (TRVI) annual income statement — 10-year revenue, gross profit & net income history

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Sales/Revenue	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Revenue Growth %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Goods Sold	0	34K	0	0	0	0	38K	0	38K	35K	35K	0	0	0	0	0	0	0	12K	0
COGS % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	-34K	0	0	0	0	-38K	0	-38K	-35K	-35K	0	0	0	0	0	0	0	-12K	0
Gross Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit Growth %	-	-	100%	-	100%	100%	-8.57%	-	-	-	-	-	-	-	100%	-	-	-	-	-
Operating Expenses	20.51M	14.91M	10.22M	13.92M	13.72M	11.47M	12.21M	14.09M	13.25M	11.87M	8.9M	9.04M	8.38M	7.56M	6.66M	8.4M	7.82M	7.03M	8.27M	6.95M
OpEx % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Selling, General & Admin	5.36M	4.97M	4.03M	3.83M	4.33M	3.66M	2.88M	2.86M	3.23M	3.07M	2.38M	2.72M	2.54M	2.56M	2.34M	2.64M	2.72M	2.38M	2.09M	2.23M
SG&A % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Research & Development	15.15M	9.94M	6.19M	10.09M	9.39M	7.81M	9.33M	11.22M	10.02M	8.8M	6.52M	6.32M	5.84M	5M	4.32M	5.77M	5.1M	4.64M	6.18M	4.72M
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Operating Income	-20.51M	-14.91M	-10.22M	-13.92M	-13.72M	-11.47M	-12.24M	-14.09M	-13.29M	-11.91M	-8.93M	-9.04M	-8.38M	-7.56M	-6.66M	-8.4M	-7.82M	-7.03M	-8.27M	-6.95M
Operating Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income Growth %	-49.46%	-30.01%	16.52%	1.21%	-3.26%	3.66%	-37.05%	-55.74%	-58.54%	-57.42%	-34.19%	-7.61%	-7.19%	-7.66%	19.53%	-20.99%	14.69%	13.15%	10.01%	4.1%
EBITDA	-20.48M	-14.88M	-10.19M	-13.88M	-13.68M	-11.43M	-12.21M	-14.05M	-13.25M	-11.87M	-8.9M	-9.01M	-8.35M	-7.54M	-6.64M	-8.4M	-7.81M	-7.01M	-8.26M	-6.93M
EBITDA Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA Growth %	-49.63%	-30.13%	16.52%	1.23%	-3.27%	3.69%	-37.17%	-55.95%	-58.73%	-57.36%	-33.97%	-7.31%	-6.86%	-7.56%	19.6%	-21.08%	14.67%	13.15%	10.01%	4.11%
D&A (Non-Cash Add-back)	34K	34K	31K	38K	38K	37K	38K	36K	38K	35K	35K	35K	34K	19K	15K	9K	8K	11K	12K	13K
EBIT	-17.82M	-13.21M	-8.33M	-11.82M	-12.32M	-10.35M	-11.4M	-13.27M	-12.36M	-10.91M	-7.8M	-7.71M	-7.02M	-6.18M	-5.25M	-7.98M	-7.76M	-7.03M	-8.22M	-6.95M
Net Interest Income	2.7M	1.7M	1.9M	2.1M	1.41M	1.13M	842K	825K	934K	997K	1.13M	1.18M	1.05M	990K	843K	132K	-100K	-298K	-306K	-301K
Interest Income	2.7M	1.7M	1.9M	2.1M	1.41M	1.13M	843K	826K	935K	998K	1.14M	1.18M	1.21M	1.22M	1.12M	424K	195K	4K	3K	2K
Interest Expense	0	0	0	0	0	0	1K	1K	1K	1K	4K	3K	151K	231K	274K	292K	295K	302K	309K	303K
Other Income/Expense	2.69M	1.7M	1.89M	2.1M	1.4M	1.12M	844K	814K	929K	996K	1.13M	1.33M	1.21M	1.16M	1.13M	132K	-236K	-309K	-253K	-306K
Pretax Income	-17.82M	-13.21M	-8.33M	-11.82M	-12.32M	-10.35M	-11.4M	-13.27M	-12.36M	-10.91M	-7.8M	-7.71M	-7.17M	-6.41M	-5.53M	-8.27M	-8.06M	-7.33M	-8.53M	-7.25M
Pretax Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income Tax	-19K	-20K	-16K	-15K	-21K	-11K	16K	-31K	-8K	-8K	18K	-13K	-30K	-7K	-20K	-7K	-4K	-5K	-6K	2K
Effective Tax Rate %	0.11%	0.15%	0.19%	0.13%	0.17%	0.11%	-0.14%	0.23%	0.06%	0.07%	-0.23%	0.17%	0.42%	0.11%	0.36%	0.08%	0.05%	0.07%	0.07%	-0.03%
Net Income	-17.8M	-13.19M	-8.32M	-11.8M	-12.3M	-10.34M	-11.41M	-13.24M	-12.35M	-10.9M	-7.82M	-7.7M	-7.14M	-6.4M	-5.5M	-8.27M	-8.05M	-7.33M	-8.52M	-7.25M
Net Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income Growth %	-44.68%	-27.58%	27.15%	10.87%	0.41%	5.16%	-45.95%	-72.02%	-72.88%	-70.32%	-42.07%	6.87%	11.26%	12.66%	35.39%	-13.94%	17.79%	12.45%	10.53%	1.67%
Net Income (Continuing)	-17.8M	-13.19M	-8.32M	-11.8M	-12.3M	-10.34M	-11.41M	-13.24M	-12.35M	-10.9M	-7.82M	-7.7M	-7.14M	-6.4M	-5.5M	-8.27M	-8.05M	-7.33M	-8.52M	-7.25M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	-0.11	-0.09	-0.06	-0.08	-0.09	-0.09	-0.11	-0.13	-0.12	-0.11	-0.08	-0.08	-0.07	-0.06	-0.06	-0.12	-0.14	-0.24	-0.39	-0.34
EPS Growth %	-16.53%	-3.07%	48%	38.46%	21.33%	20.09%	-39.95%	-67.74%	-65.75%	-69.49%	-40.11%	35.42%	48.29%	72.96%	85.62%	64.71%	71.43%	44.19%	23.53%	17.07%
EPS (Basic)	-0.11	-0.09	-0.06	-0.08	-0.09	-0.09	-0.11	-0.13	-0.12	-0.11	-0.08	-0.08	-0.07	-0.06	-0.06	-0.12	-0.14	-0.24	-0.39	-0.34
Diluted Shares Outstanding	156.6M	145.59M	145.5M	145.1M	130.35M	117.61M	106.01M	101.04M	101.04M	99.52M	99.49M	99.33M	98.7M	98.61M	98.13M	68.9M	59.54M	30.81M	21.61M	21.61M
Basic Shares Outstanding	156.6M	145.59M	145.5M	145.1M	130.35M	117.61M	106.01M	101.04M	101.04M	99.52M	99.49M	99.33M	98.7M	98.61M	98.13M	68.9M	59.54M	30.81M	21.61M	21.61M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-